Artwork

Content provided by MDedge and Medscape Professional Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MDedge and Medscape Professional Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Highlights from the 2021 American Contact Dermatitis Society Meeting

20:24
 
Share
 

Manage episode 290560508 series 2356616
Content provided by MDedge and Medscape Professional Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MDedge and Medscape Professional Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This week, Amber Atwater, MD, the immediate past president of the American Contact Dermatitis Society, reviews some highlights from the meeting, which was held in March.

Dr. Atwater, associate professor of dermatology at Duke University, Durham, N.C., discusses the 2021 “Contact Allergen of the Year,” a chemical that has been linked to reactions associated with shin pads and is an emerging allergen that was the topic of a recent report in Dermatitis.

Joining Dr. Atwater, Raina Bembry, MD, a dermatitis fellow at Duke University, provides the results of a study of shoe allergens she presented at the meeting. which found that about 20% of shoe allergens are not detected with the current screening series. Dr. Atwater and Dr. Bembry are first and second authors of this paper, respectively; other authors are members of the North American Contact Dermatitis Group.

Dr. Atwater also reviews the results of a study on the potential role of expanded series patch testing in residual facial dermatitis in patients treated with dupilumab (which received the Gold Alexander A. Fisher Resident Award at the meeting), a study on patterns of contact allergy in Black and White patients in Philadelphia over 10 years (which received the Silver Fisher Resident Award), a study of contact dermatitis information on different social media sites, and results of NACDG patch test results from 2017 to 2018.

Dr. Atwater disclosed receiving the Pfizer Independent Grant for Learning & Change and consulting for Henke. Dr. Bembry had no disclosures.

References:

https://www.mdedge.com/dermatology/article/237677/contact-dermatitis/contact-allergen-year-found-foam-shin-guards-footwear

https://www.mdedge.com/dermatology/article/237834/contact-dermatitis/check-all-components-cases-suspected-shoe-allergy

https://www.mdedge.com/dermatology/article/237899/contact-dermatitis/contact-dermatitis-content-varies-among-social-media

* * *

You can find more of our podcasts at http://www.mdedge.com/podcasts

Email the show: podcasts@mdedge.com

  continue reading

106 episodes

Artwork
iconShare
 
Manage episode 290560508 series 2356616
Content provided by MDedge and Medscape Professional Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MDedge and Medscape Professional Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This week, Amber Atwater, MD, the immediate past president of the American Contact Dermatitis Society, reviews some highlights from the meeting, which was held in March.

Dr. Atwater, associate professor of dermatology at Duke University, Durham, N.C., discusses the 2021 “Contact Allergen of the Year,” a chemical that has been linked to reactions associated with shin pads and is an emerging allergen that was the topic of a recent report in Dermatitis.

Joining Dr. Atwater, Raina Bembry, MD, a dermatitis fellow at Duke University, provides the results of a study of shoe allergens she presented at the meeting. which found that about 20% of shoe allergens are not detected with the current screening series. Dr. Atwater and Dr. Bembry are first and second authors of this paper, respectively; other authors are members of the North American Contact Dermatitis Group.

Dr. Atwater also reviews the results of a study on the potential role of expanded series patch testing in residual facial dermatitis in patients treated with dupilumab (which received the Gold Alexander A. Fisher Resident Award at the meeting), a study on patterns of contact allergy in Black and White patients in Philadelphia over 10 years (which received the Silver Fisher Resident Award), a study of contact dermatitis information on different social media sites, and results of NACDG patch test results from 2017 to 2018.

Dr. Atwater disclosed receiving the Pfizer Independent Grant for Learning & Change and consulting for Henke. Dr. Bembry had no disclosures.

References:

https://www.mdedge.com/dermatology/article/237677/contact-dermatitis/contact-allergen-year-found-foam-shin-guards-footwear

https://www.mdedge.com/dermatology/article/237834/contact-dermatitis/check-all-components-cases-suspected-shoe-allergy

https://www.mdedge.com/dermatology/article/237899/contact-dermatitis/contact-dermatitis-content-varies-among-social-media

* * *

You can find more of our podcasts at http://www.mdedge.com/podcasts

Email the show: podcasts@mdedge.com

  continue reading

106 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide